Stephen Huhn
Chief Tech/Sci/R&D Officer at CONTINEUM THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Profile
Stephen L.
Huhn is currently the Chief Medical Officer & SVP-Clinical Development at Contineum Therapeutics, Inc. He previously worked as the Chief Medical Officer & VP-CNS Clinical Research at StemCells, Inc. from 2014 to 2015.
Prior to that, he held the position of Associate Professor-Neurosurgery at Stanford University.
Dr. Huhn obtained his doctorate degree from the University of Arizona in 1987.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-03 | 0 ( -.--% ) | - $ | 2024-04-29 |
Stephen Huhn active positions
| Companies | Position | Start |
|---|---|---|
| CONTINEUM THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Former positions of Stephen Huhn
| Companies | Position | End |
|---|---|---|
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Chief Tech/Sci/R&D Officer | - |
| Stanford University | Corporate Officer/Principal | - |
Training of Stephen Huhn
| University of Arizona | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CONTINEUM THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Stock Market
- Insiders
- Stephen Huhn